JACLYN KLEINSCHRODT: Open Payments
NPI 1649765751 · MANCHESTER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,268 in 46 payments from 19 companies in 2025. Trend: 2023 $1,777 · 2024 $2,581 · 2025 $1,268
Food & beverage: $1,178Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $402 |
| Sumitomo Pharma America, Inc. | 8 | $152 |
| PFIZER INC. | 4 | $99 |
| Astellas Pharma US Inc | 3 | $70 |
| UROGEN PHARMA, INC. | 3 | $69 |
| TOLMAR, INC. | 3 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| IMMUNITYBIO, INC. | 2 | $41 |
Products named: RYBREVANT, ERLEADA, Xtandi, ORGOVYX, Nubeqa, LYNPARZA, ELIGARD, PLUVICTO.
Industry payments across NH — which companies pay providers there.
